The Outlook for Emerging Central American Pharmaceutical Markets 2009

Summary

Incorporating much original information, this report shines a critical light on seven markets in the region, assessing their status and potential in the current economic and market conditions: Costa Rica, El Salvador, Honduras, Guatemala, Mexico, Nicaragua and Panama.

Contents

Foreword

Regional overview

EXECUTIVE SUMMARY

• Summary of Key Data Projections in Central America, 2008-2013

POLITICAL ANALYSIS

ECONOMIC ANALYSIS

• Projected GDP in Central & Latin America, 2008-2013 (US$ Billions)
• Projected GDP Real Growth in Central & Latin America, 2008-2013 (%)
• Projected GDP Per Capita in Central & Latin America, 2008-2013 (US$)
• Projected Inflation Growth in Central & Latin America, 2008-2013 (%)

HEALTHCARE ANALYSIS

• Demographics
• Population
• Projected Population in Central & Latin America, 2008-2013 (Millions)
• Projected Population Growth in Central & Latin America, 2008-2013 (%)
• Projected Population Aged 65+ in Central & Latin America, 2008-2013 (Millions)
• Projected Population Aged 65+ in Central & Latin America, 2008-2013 (%)
• Public Health
• Summary of Demographic Data in Central America
• Health Expenditure
• Projected Health Expenditure in Central & Latin America, 2008-2013 (US$ Billions)
• Projected Health Expenditure per Capita in Central & Latin America, 2008-2013 (US$)
• Projected Health Expenditure as % of GDP in Central & Latin America, 2008-2013
• Projected Private Health Expenditure in Central & Latin America, 2008-2013 (%)

PHARMACEUTICAL REGULATORY ANALYSIS

• Pharmaceutical Regulation
• Health Authorities in Central America, 2008
• Pharmacopoeias Accepted in Central America, 2007
• Legal Requirements for NCE Registrations in Central America, 2007
• Technical Requirements for NCE Registrations in Central America, 2007
• Approval Times & Fees for NCE Registrations in Central America, 2007
• Legal Requirements for Renewals in Central America, 2007
• Technical Requirements for Renewals in Central America, 2007
• Approval Times & Fees for Renewals in Central America, 2007
• SIECA.s Resolutions Affecting Pharmaceuticals, 2002-2008
• Intellectual Property
• IPR Summary in Central America, 2008
• Pricing & Reimbursement
• Drug Pricing Summary in Central America, 2008

PHARMACEUTICAL DISTRIBUTION ANALYSIS

• Wholesaling
• Retailing
• Ranking of Central American Pharmacy Chains, 2006

PHARMACEUTICAL MARKET ANALYSIS

• Projections
• Pharmaceutical Market Projections of Central & Latin America, 2008-2013 (US$ Billions)
• Pharmaceutical Market Projections of Central & Latin America, 2008-2013 (%)
• Pharmaceutical Market Projections per Capita of Central & Latin America, 2008-2013 (US$)
• Private Pharmacy Sector of Central & Latin America, 2005-2007 (US$ Millions)
• SWOT Analysis of the Central American Pharmaceutical Market, 2008
• Imports
• Pharmaceutical Imports in Central & Latin America, 2002-2006 (US$ Millions)
• Domestic Production
• Trade Associations
• ALIFAR
• Members of ALIFAR, 2008

FEDEFARMA

• Members of FEDEFARMA, 2008

FIFARMA

• Members of FIFARMA, 2007
• FIFCCA
• Local Manufacturers
• Multinational Manufacturers
• Exports
• Pharmaceutical Exports in Central & Latin America, 2002-2006 (US$ Millions)
• Balance of Pharmaceutical Trade in Central & Latin America, 2002-2006 (US$ Millions)
• Research & Development
• Costa Rica

EXECUTIVE SUMMARY

• Summary of Key Data Projections, 2008-2013

GEOGRAPHY

POLITICAL ANALYSIS

ECONOMIC ANALYSIS

• GDP, 2008-2013

HEALTHCARE ANALYSIS

• Demographics
• Population
• Population, 2008-2013
• Population by Province, Age & Sex, 2006
• Population by Province, Age & Sex, 2006 (%)
• Public Health
• Demographic Indicators, 2000-2007
• Causes of Death, 2001-2006
• Causes of Death by Sex, 2006
• AIDS Mortality by Sex, 1985-2007
• Infectious Diseases, 2000-2006
• Healthcare System
• Organisation & Administration
• Health Insurance
• Population Directly Insured by the Sickness & Maternity Insurance, 2000-2007
• Population Directly Insured by the Sickness & Maternity Insurance, 2000-2007 (%)
• Health Expenditure
• Health Expenditure, 2008-2013
• Public Health Expenditure
• Public Health Expenditure, 2000-2007
• Public Health Expenditure by Provider, 2003-2007 (CRC Billion)
• Healthcare Infrastructure
• Hospital Resources
• CCSS Hospital Bed Indicators, 2000-2006
• CCSS Hospital Beds by Specialty, 2001-2006
• CCSS Bed Indicators by Hospital, 2006
• CCSS Hospital Beds by Specialty & Hospital, 2006
• Hospital Activity
• CCSS Hospital Activity, 2000-2006
• CCSS Discharges by Specialty, 2000-2006
• CCSS Hospital Activity by Hospital/Area, 2006
• CCSS Discharges by Specialty & Hospital/Area, 2006
• CCSS Diagnostic Procedures, 2000-2006
• CCSS Diagnostic Procedures by Care Area, 2006
• Outpatient Resources
• EBAIS by Province, 2006
• Health Centres, 2002
• Outpatient Activity
• CCSS Outpatient & Emergency Consultations, 2001-2006
• CCSS Outpatient & Emergency Consultations by Region, 2006
• Medical Personnel
• Doctors, Nurses & Dentists, 2003-2006
• CCSS Medical Personnel, 2000-2007
• CCSS Auxiliary & Technical Healthcare Personnel, 2000-2007

PHARMACEUTICAL REGULATORY ANALYSIS

• Pharmaceutical Regulation
• Registration
• Advertising
• Packaging & Labelling
• Intellectual Property
• Pricing & Reimbursement
• Reimbursement

PHARMACEUTICAL DISTRIBUTION ANALYSIS

• Wholesaling
• Distributors
• Retailing

PHARMACEUTICAL MARKET ANALYSIS

• Current Size
• Summary of the Costa Rican Pharmaceutical Market, 2008
• Market Structure
• Market Structure, 1998-2006 (US$ Million)
• CCSS Sector
• CCSS Market Value, 2007-2008
• CCSS Market Volume by Care Area, 2002-2006 (Million Units)
• CCSS Market Volume by Region, 2002-2006 (Million Units)
• Projections
• Market Projections, 2008-2013
• SWOT Analysis of the Costa Rican Pharmaceutical Market, 2008
• Imports
• Pharmaceutical Imports by Category, 2002-2006 (US$ Million)
• Leading Pharmaceutical Suppliers by Category, 2006 (US$ Million)
• Leading Pharmaceutical Suppliers by Category, 2006 (%)
• Domestic Production
• Domestic Production, 1995-2002
• Trade Associations
• ASIFAN
• Domestic Producers
• Alcames
• Calox de Costa Rica
• LACOFA
• Lisan
• Merck Sharp & Dohme
• NPCR
• Stein
• Zepol
• Exports
• Pharmaceutical Exports, 2003-2007 (US$ Million)
• Leading Pharmaceutical Exporters, 2003-2007 (US$ Million)
• Leading Pharmaceutical Destinations, 2003-2007 (US$ Million)
• Leading Pharmaceutical Destinations, 2003-2007 (Tons)
• Research & Development
• El Salvador

EXECUTIVE SUMMARY

• Summary of Key Data Projections, 2008-2013

GEOGRAPHY

POLITICAL ANALYSIS

ECONOMIC ANALYSIS

• GDP, 2008-2013

HEALTHCARE ANALYSIS

• Demographics
• Population
• Population, 2008-2013
• Population by Department, 2007 Census
• Public Health
• Demographic Indicators, 2005-2007
• Ten Leading Causes of Death by Gender, 2006
• AIDS Deaths, 2000-2007
• Infectious Diseases, 2005-2007
• Vaccination Coverage, 2005-2007 (%)
• HIV/AIDS Cases, 1984-2007
• Antiretroviral Therapy Patients, 2001-2006
• Healthcare System
• Organisation & Administration
• Health Expenditure
• Health Expenditure, 2008-2013
• Health Expenditure by Sector, 2006
• Public Health Expenditure by Provider, 2006
• MSPAS Health Expenditure, 2003-2007 (US$ Million)
• MSPAS Health Expenditure by Type, 2005-2007 (US$ Million)
• Healthcare Infrastructure
• Hospital Resources
• MSPAS Infrastructure, 2003-2007
• MSPAS Hospital Infrastructure by SIBASI, 2007
• MSPAS Diagnostic Infrastructure, 2003-2007
• MSPAS Hospital Diagnostic Infrastructure by SIBASI, 2007
• Hospital Activity
• MSPAS Hospital Activity, 2003-2007
• MSPAS Diagnostic Activity, 2003-2007
• MSPAS Diagnostic Activity by Provider, 2007
• Outpatient Resources
• MSPAS Outpatient Infrastructure, 2003-2007
• MSPAS Outpatient Infrastructure by SIBASI, 2007
• MSPAS Other Outpatient Infrastructure by SIBASI, 2007
• MSPAS Outpatient Diagnostic Infrastructure by SIBASI, 2007
• Outpatient Activity
• MSPAS Medical Consultations by Type, 2003-2007
• MSPAS Medical Consultations by Provider, 2007
• MSPAS Dentist Consultations by Provider, 2003-2007
• Medical Personnel
• MSPAS Personnel, 2006

PHARMACEUTICAL REGULATORY ANALYSIS

• Pharmaceutical Regulation
• Registration
• Packaging & Labelling
• Manufacturing Licence
• Intellectual Property
• Pricing & Reimbursement

PHARMACEUTICAL DISTRIBUTION ANALYSIS

• Retailing
• Pharmacy Chains
• Econmicas
• Meykos
• San Nicols

PHARMACEUTICAL MARKET ANALYSIS

• Current Size
• Summary of the Salvadorian Pharmaceutical Market, 2008
• Market Structure
• MSPAS Medical Prescriptions, 2003-2007
• MSPAS Pharmaceutical Suppliers, 2007 & 2008
• Projections
• Market Projections, 2008-2013
• SWOT Analysis of the Salvadorian Pharmaceutical Market, 2008
• Imports
• Pharmaceutical Imports by Category, 2002-2006 (US$ Million)
• Leading Pharmaceutical Suppliers by Category, 2006 (US$ Million)
• Leading Pharmaceutical Suppliers by Category, 2006 (%)
• Domestic Production
• Pharmaceutical Production by Number of Employees, 2004
• Pharmaceutical Production by Turnover, 2004
• Trade Associations

INQUIFAR

• ASI
• Pharmaceutical Members of ASI, 2008
• Domestic Producers
• Ancalmo
• Arsal
• Bayer
• Gamma
• Lpez
• Suizos
• Teramed
• Vijosa
• Exports
• Pharmaceutical Exports by Category, 2002-2004 (US$ Million)
• Leading Pharmaceutical Destinations by Category, 2004 (US$ Million)
• Leading Pharmaceutical Destinations by Category, 2004 (%)
• Guatemala

EXECUTIVE SUMMARY

• Summary of Key Data Projections, 2008-2013

GEOGRAPHY

POLITICAL ANALYSIS

ECONOMIC ANALYSIS

• GDP, 2000-2009

HEALTHCARE ANALYSIS

• Demographics
• Population
• Population by Age Group, 2005, 2010 & 2015
• Population, 2000-2009
• Population by Sex, Area & Department, 2002 Census
• Public Health
• Demographic Indicators, 2000-2005
• Causes of Death, 2001-2006
• Causes of Death by Sex, 2006
• Infectious Diseases, 2004-2006
• Healthcare System
• Organisation & Administration
• IGSS Coverage, 2000-2006
• Health Expenditure
• Health Expenditure, 2006-2013
• Health Expenditure by Sector, 2005
• MSPAS Health Expenditure
• MSPAS Health Expenditure by Type, 2006
• MSPAS Health Expenditure on Primary Care by Health Area, 2005
• MSPAS Health Expenditure on Hospital Care by Health Area & Hospital, 2005
• Healthcare Infrastructure
• Hospital Resources
• MSPAS Hospitals by Type, 2005 & 2006
• MSPAS Hospitals by Type & Health Area, 2005
• MSPAS Beds by Health Area & Hospital, 2005
• IGSS Beds by Department & Hospital/Consulting Office, 2006
• Hospital Activity
• MSPAS Hospital Activity, 2005 & 2006
• IGSS Hospital Activity, 2006
• MSPAS Diagnostic Procedures, 2005 & 2006
• MSPAS Hospital Activity by Health Area & Hospital, 2005
• MSPAS Diagnostic Procedures by Health Area & Hospital, 2005
• Outpatient Resources
• MSPAS Outpatient Resources, 2005 & 2006
• MSPAS Health Centres & Posts by Health Area, 2005
• IGSS Outpatient Resources, 2006
• Outpatient Activity
• MSPAS Outpatient Activity by Health Area, 2005
• IGSS Outpatient Activity, 2006
• Medical Personnel
• IGSS Medical Personnel, 2006

PHARMACEUTICAL REGULATORY ANALYSIS

• Pharmaceutical Regulation
• Pharmaceutical Registration
• Packaging & Labelling
• Advertising
• Intellectual Property
• Pricing & Reimbursement

PHARMACEUTICAL DISTRIBUTION ANALYSIS

• Retailing
• Pharmacy Chains

PHARMACEUTICAL MARKET ANALYSIS

• Current Size
• Summary of the Guatemalan Pharmaceutical Market, 2008
• Projections
• Market Projections, 2008-2013
• SWOT Analysis of the Guatemalan Pharmaceutical Market, 2008
• Imports
• Pharmaceutical Imports by Category, 2002-2005 (US$ Million)
• Leading Pharmaceutical Suppliers by Category, 2005 (US$ Million)
• Leading Pharmaceutical Suppliers by Category, 2005 (%)
• Domestic Production
• Pharmaceutical Producers, 2007
• Trade Associations

ASINFARGUA

• Members of ASINFARGUA, 2008
• CMARA DE INDUSTRIA DE GUATEMALA
• Domestic Producers
• Bayer
• Bonin
• Donovan Werke
• INFASA
• LAFOFA
• Lancasco
• Mediproducts
• Piersan
• Qualipharm
• Exports
• Pharmaceutical Exports by Category, 2002-2005 (US$ Million)
• Leading Pharmaceutical Destinations by Category, 2005 (US$ Million)
• Leading Pharmaceutical Destinations by Category, 2005 (%)
• Honduras

EXECUTIVE SUMMARY

• Summary of Key Data Projections, 2008-2013

GEOGRAPHY

POLITICAL ANALYSIS

ECONOMIC ANALYSIS

• GDP, 2000-2009

HEALTHCARE ANALYSIS

• Demographics
• Population
• Population, 2000-2009
• Population by Department & Sex, August 2008
• Population by City, 2003-2007 (000s)
• Public Health
• Demographic Indicators, 1990, 2000 & 2006
• Cumulative HIV/AIDS Cases by Year, December 2007
• Cumulative HIV/AIDS Cases by Transmission Type, January 2007
• HIV Projections in the Adult Population, 2008-2012
• HIV Estimates, 2002-2006
• Healthcare System
• Organisation & Administration
• IHSS Coverage, 2003-2007
• IHSS Coverage by City, 2003-2007
• Health Expenditure
• Estimated Health Expenditure, 2005-2009
• Hospital Infrastructure
• Hospital Resources
• Hospitals by Sector, 2003-2007
• SS Hospitals by Location & Department, 2007
• Hospital Beds, 2001-2007
• Outpatient Resources
• SS Health Centres, 2001-2007
• SS Peripheral Clinics (CLIPER) by Location & Department, 2007
• Medical Personnel
• Medical Personnel, 2006-2009
• SS & IHSS Personnel, 2004

PHARMACEUTICAL REGULATORY ANALYSIS

• Pharmaceutical Regulation
• Pharmaceutical Registration
• Intellectual Property
• Pricing & Reimbursement
• Reimbursement

PHARMACEUTICAL DISTRIBUTION ANALYSIS

• Retailing
• Fines to Pharmacy Chains & Associations, July 2008

PHARMACEUTICAL MARKET ANALYSIS

• Current Size
• Summary of the Honduran Pharmaceutical Market, 2008
• Market Structure
• Private Pharmacy Sector
• Public Sector
• Projections
• Market Projections, 2008-2013
• SWOT Analysis of the Honduran Pharmaceutical Market, 2008
• Imports
• Pharmaceutical Imports by Category, 2002-2006 (US$ Million)
• Leading Pharmaceutical Suppliers by Category, 2006 (US$ Million)
• Leading Pharmaceutical Suppliers by Category, 2006 (%)
• Domestic Production
• Trade Association

ANAPROHFAR

• Domestic Producers
• Andifar

CORINFAR

• Everest
• Farsimn
• Finlay
• Francelia
• Grupo Pharma Internacional

INFARMA

• Karnel
• LAN
• Mapeca
• MC
• Nacional
• Pharmaetica
• Sandoval
• Exports
• Pharmaceutical Exports by Category, 2002-2006 (US$ Million)
• Leading Pharmaceutical Destinations by Category, 2005 (US$ Million)
• Leading Pharmaceutical Destinations by Category, 2005 (%)
• Mexico

EXECUTIVE SUMMARY

• Summary of Key Data Projections, 2008-2013

GEOGRAPHY

POLITICAL ANALYSIS

ECONOMIC ANALYSIS

• GDP, 2008-2013

HEALTHCARE ANALYSIS

• Demographics
• Population
• Projected Population, 2008-2013
• Projected Population by State, 2009
• Public Health
• Demographic Indicators, 2000-2007
• Leading Causes of Death, 2001-2008
• Leading Reportable Diseases, 2007
• Healthcare System
• Organisation & Administration
• Social Security
• Health Expenditure
• Projected Health Expenditure, 2008-2013
• Healthcare Expenditure by Sector, 2000-2007
• Public Health Expenditure by Source of Funding, 2000-2007
• Healthcare Infrastructure
• Hospital Resources
• Public Hospitals by Provider, 2000-2008
• Private Hospitals by Bed Size, 2000-2008
• Active Hospital Beds by Sector, 2000-2008
• Public Active Hospital Beds by Provider, 2000-2008
• Private Active Hospital Beds by State, 2002-2007
• Mdica Sur.s Revenues, 2004-2007 (Million Pesos)
• Hospital Activity
• Hospital Discharges by Sector, 2001-2008 (000s)
• Public Hospital Discharges by Provider, 2000-2008 (000s)
• Private Hospital Activity, 2000-2008 (000s)
• Hospital Surgical Procedures by Sector, 2001-2008 (000s)
• Public Hospital Surgical Procedures by Provider, 2000-2008
• Outpatient Resources
• Public Outpatient Units by Provider, 2000-2008
• Consulting Rooms by Sector, 2000-2008
• Public Consulting Rooms by Provider, 2000-2008
• Private Consulting Rooms by State, 2002-2007
• Outpatient Activity
• Outpatient Consultations by Sector, 2000-2008 (000s)
• Public Outpatient Consultations by Provider, 2000-2008 (000s)
• Private Outpatient Consultations by Type, 2000-2008 (000s)
• Healthcare Personnel
• Doctors by Sector, 2000-2008
• Public Doctors by Provider, 2000-2008
• Private Doctors by State, 2005-2007

PHARMACEUTICAL REGULATORY ANALYSIS

• Pharmaceutical Regulation
• Regulatory Developments for Biologics
• Medical Samples Regulatory Developments
• Manufacturing Regulatory Developments
• Pharmaceutical Registration
• Legal Pharmaceutical Registration Requirements
• Technical, Preclinical & Clinical Registration Requirements
• NOM-177-SSA1-1998.s Generic Tests
• Time for Registration Approval & Fees
• Registration Renewals
• Registration Renewal Requirements
• Import Regulations
• Import Fees Applicable from 1st January 2007
• Advertising
• Intellectual Property
• Pricing & Reimbursement
• Pricing in the Private Pharmacy Sector
• Pricing in the Public Sector
• Reimbursement

PHARMACEUTICAL DISTRIBUTION ANALYSIS

• Wholesaling
• Distribution Associations
• Distributors
• GCS.s Sales, 2003-QII 2008
• Retailing
• Pharmacy Associations
• Members of ANADIM, 2007
• Pharmacy Chains
• Farmacias Benavides. Figures, 2002-QIII 2008
• Corporativo Fragua.s Figures, 2002-QIII 2008

PHARMACEUTICAL MARKET ANALYSIS

• Current Size
• Summary of the Mexican Pharmaceutical Market, 2008
• Market Structure
• Private Pharmacy & Public Sectors by Value, 2008 (US$ Million)
• Generics Sector
• OTC Sector
• Public Sector
• Public Pharmaceutical Expenditure by Provider, 2007 (Million Pesos)
• Public Pharmaceutical Expenditure by Provider, 2004-2007 (Million Pesos)
• Change in Public Pharmaceutical Expenditure by Provider, 2005-2007 (%)
• Public Pharmaceutical Expenditure by Provider, 2004-2007 (US$ Million)
• Projections
• Market Projections, 2008-2013
• SWOT Analysis of the Pharmaceutical Market, 2008
• Imports
• Pharmaceutical Imports by Category, 2002-2006 (US$000s)
• Pharmaceutical Import Trends by Category, 2005-2006 (US$000s)
• Leading Suppliers of Raw Materials, 2006 (US$000s)
• Leading Suppliers of Antisera & Vaccines, 2006 (US$000s)
• Leading Suppliers of Medicaments, 2006 (US$000s)
• Domestic Production
• Pharmaceutical Production Indicators, 1999-2006
• Pharmaceutical Production Breakdown, 2000-2005 (Billion Pesos)
• Trade Associations

AFAMELA

• Members of AFAMELA, 2007
• AMEGI
• Members of AMEGI, 2008
• AMELAF
• AMIIF
• Members of AMIIF, 2008
• ANAFAM
• Members of ANAFAM, 2007
• ANAPIF

CANIFARMA

• Members of CANIFARMA, 2007
• Trade Fairs
• EXPOFARMA INTERPHEX 2009
• ExpoSALUD y Bienestar
• Local Manufacturers
• Genomma Lab
• Genomma Lab.s Sales by Destination, 2005-2007 (Million Pesos)
• Genomma Lab.s National Sales by Sector, 2005-2007 (Million Pesos)
• Genomma Lab.s Bestsellers by Sales, 2007
• IFA Celtics
• Landsteiner Scientific
• Liomont
• Pisa Farmacutica
• Probiomed
• Senosiain
• Silanes
• Sophia
• Multinational Manufacturers
• Armstrong
• AstraZeneca
• AstraZeneca.s Sales, 2005-2006
• Bayer
• Boehringer Ingelheim Promeco
• Bristol-Myers Squibb
• Eli Lilly
• GlaxoSmithKline
• Merck
• Merck Sharp & Dohme
• Novartis
• Novartis Sales by Division, 2007
• Perrigo
• Pfizer
• Roche
• sanofi-aventis
• Schering-Plough
• Solvay Pharmaceuticals
• Teva
• Wyeth
• Exports
• Pharmaceutical Exports by Category, 2002-2006 (US$000s)
• Pharmaceutical Export Trends by Category, 2005-2006 (US$000s)
• Leading Destinations of Pharmaceuticals, 2006 (US$000s)
• Research & Development
• Clinical Studies, 2003-2006
• Nicaragua

EXECUTIVE SUMMARY

• Summary of Key Data Projections, 2008-2013

GEOGRAPHY

POLITICAL ANALYSIS

ECONOMIC ANALYSIS

• GDP, 2000-2009

HEALTHCARE ANALYSIS

• Demographics
• Population
• Population, 2000-2009
• Population by Department/Autonomous Region & Sex, 2005 Census
• Population by Age Group & Sex, 2005 Census
• Public Health
• Estimated Five-Year Demographic Indicators, 1990-2005
• Estimated & Reported Births & Deaths, 2000-2002
• Reported Deaths by Cause, 2005
• Reported Deaths by Cause, 1985-2005 (%)
• Morbidity Indicators, 2005
• Malaria & Tuberculosis Rates, 1990-2005
• Vaccination Coverage, 2002-2005 (%)
• Cumulative HIV/AIDS Cases by SILAIS, 1987-June 2007
• Healthcare System
• Organisation & Administration
• INSS Affiliated Population by Type of Affiliation, 1994-2006
• INSS Insured Population Affiliated to Contracted Clinics, 1996-2006
• Health Expenditure
• Estimated Health Expenditure, 2005-2009
• Health Expenditure by Sector, 2004
• Hospital Infrastructure
• Hospital Resources
• MINSA Hospitals & Hospital Beds, 2000-2005
• MINSA Hospital Beds by Department/Autonomous Region, 2005
• INSS Contracted Clinics by Number of Affiliated Population, 2006
• Hospital Activity
• MINSA Activity, January-June 2005-2008
• MINSA Activity by Department/Autonomous Region, 2005
• MINSA Activity, 2000-2002
• INSS Activity, 2000-2006
• Outpatient Resources
• MINSA Ambulatory Network, 2000-2002
• MINSA Ambulatory Consultations by Department/Autonomous Region, 2005
• Medical Personnel
• MINSA Medical Personnel, 2000-2005
• MINSA Medical Personnel by Department/Autonomous Region, 2000-2005

PHARMACEUTICAL REGULATORY ANALYSIS

• Pharmaceutical Regulation
• Pharmaceutical Registration
• Intellectual Property
• Pricing & Reimbursement
• Reimbursement

PHARMACEUTICAL DISTRIBUTION ANALYSIS

PHARMACEUTICAL MARKET ANALYSIS

• Current Size
• Summary of the Nicaraguan Pharmaceutical Market, 2008
• Market Structure
• Private Pharmacy Sector
• Public Sector
• Projections
• Market Projections, 2008-2013
• SWOT Analysis of the Nicaraguan Pharmaceutical Market, 2008
• Imports
• Pharmaceutical Imports by Category, 2002-2006 (US$ Million)
• Leading Pharmaceutical Suppliers by Category, 2006 (US$ Million)
• Leading Pharmaceutical Suppliers by Category, 2006 (%)
• Domestic Production
• Domestic Producers
• Ceguel
• Panzyma
• RARPE
• Exports
• Pharmaceutical Exports by Category, 2002-2006 (US$ Million)
• Leading Pharmaceutical Destinations by Category, 2006 (US$ Million)
• Leading Pharmaceutical Destinations by Category, 2006 (%)
• Panama

EXECUTIVE SUMMARY

• Summary of Key Data Projections, 2008-2013

GEOGRAPHY

POLITICAL ANALYSIS

ECONOMIC ANALYSIS

• GDP, 2000-2009

HEALTHCARE ANALYSIS

• Demographics
• Population
• Population, 2000-2009
• Population by Province, Age & Sex, 2007
• Population by Province & Age, 2007 (%)
• Public Health
• Demographic Indicators, 2003-2006
• Leading Causes of Death, 2003-2006
• Cumulative AIDS Deaths by Province, 2006
• Malignant Neoplasms by Type, 2005
• Infectious Diseases, 2002-2006
• Vaccination Coverage, 2002-2005 (%)
• AIDS Cases, 1984-2006
• Cumulative AIDS Cases by Province, 2006
• Healthcare System
• Organisation & Administration
• CSS Coverage, 2002-2006
• CSS Coverage by Province, 2006
• Health Expenditure
• MINSA Health Budget, 2002-2007 (US$ Million)
• MINSA Health Budget & Expenditure by Type, 2007 (US$ Million)
• Healthcare Infrastructure
• Hospital Resources
• MINSA & CSS Hospital Infrastructure, 2007
• MINSA & CSS Hospitals by Type, 2007
• Bed Indicators by Sector, 2001-2006
• Beds by Province, 2002-2006
• MINSA & CSS Beds, 2003-2005
• MINSA & CSS Hospital Beds by Province, 2002-2005
• MINSA & CSS Hospital Beds by Province, District & Hospital, 2005-2006
• Hospital Activity
• MINSA & CSS Discharges, 2003-2005
• MINSA & CSS Discharges by Hospital Type, 2005
• MINSA Hospital External Consultations, 2003-2006
• MINSA Hospital Emergency Consultations, 2003-2006
• MINSA Hospital Diagnostic Activity, 2003-2006
• Outpatient Resources
• MINSA & CSS Outpatient Infrastructure, 2007
• MINSA Outpatient Infrastructure by Province, 2007
• CSS Outpatient Infrastructure by Province, 2007
• Outpatient Activity
• MINSA Consultations by Type, 2003-2006
• MINSA Consultations by Province, 2006
• MINSA Diagnostic Activity, 2004-2006
• Medical Personnel
• Medical Personnel, 2001-2006
• Medical Personnel by Province, 2006
• Medical Personnel in Institutions with Beds by Sector, 2001-2006

PHARMACEUTICAL REGULATORY ANALYSIS

• Pharmaceutical Regulation
• Pharmaceutical Registration
• Intellectual Property
• Pricing & Reimbursement
• Retail Pharmacy Sector
• Public Sector

PHARMACEUTICAL DISTRIBUTION ANALYSIS

• Wholesaling
• Distribution Trade Association
• Pharmaceutical Members of CCIAP, 2008
• Distributors
• Pharmacy Sector vs Impa-Doel.s Pharmaceutical Sales Growth, 2003-2006 (%)
• Impa-Doel.s Clients by Distribution Channel, 2006

PHARMACEUTICAL MARKET ANALYSIS

• Current Size
• Summary of the Panamanian Pharmaceutical Market, 2008
• Projections
• Macroenvironment Analysis
• Healthcare Analysis
• Pharmaceutical Market Analysis
• Market Projections, 2008-2013
• SWOT Analysis of the Panamanian Pharmaceutical Market, 2008
• Imports
• Pharmaceutical Imports by Category, 2002-2006 (US$ Million)
• Leading Pharmaceutical Suppliers by Category, 2006 (US$ Million)
• Leading Pharmaceutical Suppliers by Category, 2006 (%)
• Domestic Production
• Trade Association
• AREDIS
• Domestic Producers
• Rigar
• Exports
• Pharmaceutical Exports by Category, 2002-2006 (US$ Million)
• Leading Pharmaceutical Destinations by Category, 2006 (US$ Million)
• Leading Pharmaceutical Destinations by Category, 2006 (%)
• Appendix 1: Sources

REGIONAL OVERVIEW

• Espicom
• Media
• Organisations
• Trade Associations

COSTA RICA

• Government Organisations
• Trade Associations

EL SALVADOR

• Government Organisations
• Trade Associations

GUATEMALA

• Government Organisations
• Trade Associations

HONDURAS

• Government Organisations
• Trade Associations
• MEXICO
• Government Organisations
• Trade Associations

NICARAGUA

• Government Organisations
• Trade Associations
• PANAMA
• Government Organisations
• Trade Associations